These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34246701)

  • 1. Manipulation of TAMs functions to facilitate the immune therapy effects of immune checkpoint antibodies.
    Liu Y; Liang S; Jiang D; Gao T; Fang Y; Fu S; Guan L; Zhang Z; Mu W; Chu Q; Liu Y; Zhang N
    J Control Release; 2021 Aug; 336():621-634. PubMed ID: 34246701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diurnal Expression of PD-1 on Tumor-Associated Macrophages Underlies the Dosing Time-Dependent Antitumor Effects of the PD-1/PD-L1 Inhibitor BMS-1 in B16/BL6 Melanoma-Bearing Mice.
    Tsuruta A; Shiiba Y; Matsunaga N; Fujimoto M; Yoshida Y; Koyanagi S; Ohdo S
    Mol Cancer Res; 2022 Jun; 20(6):972-982. PubMed ID: 35190830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma.
    Han Z; Wu X; Qin H; Yuan YC; Schmolze D; Su C; Zain J; Moyal L; Hodak E; Sanchez JF; Lee PP; Feng M; Rosen ST; Querfeld C
    JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M2 subtype tumor associated macrophages (M2-TAMs) infiltration predicts poor response rate of immune checkpoint inhibitors treatment for prostate cancer.
    JiaWei Z; ChunXia D; CunDong L; Yang L; JianKun Y; HaiFeng D; Cheng Y; ZhiPeng H; HongYi W; DeYing L; ZhiJian L; Xiao X; QiZhao Z; KangYi X; WenBing G; Ming X; JunHao Z; JiMing B; ShanChao Z; MingKun C
    Ann Med; 2021 Dec; 53(1):730-740. PubMed ID: 34032524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy of nanodiamond-doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells.
    Xu HZ; Li TF; Wang C; Ma Y; Liu Y; Zheng MY; Liu ZJ; Chen JB; Li K; Sun SK; Komatsu N; Xu YH; Zhao L; Chen X
    J Nanobiotechnology; 2021 Sep; 19(1):268. PubMed ID: 34488792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting of TAMs in tumor immune microenvironment: Insight from NF-κB signaling pathway.
    He R; He Y; Du R; Liu C; Chen Z; Zeng A; Song L
    Biomed Pharmacother; 2023 Sep; 165():115090. PubMed ID: 37390708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression.
    Pu Y; Ji Q
    Front Immunol; 2022; 13():874589. PubMed ID: 35592338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between PD-1/PD-L1 expression and polarization in tumor-associated macrophages: A key player in tumor immunotherapy.
    Li W; Wu F; Zhao S; Shi P; Wang S; Cui D
    Cytokine Growth Factor Rev; 2022 Oct; 67():49-57. PubMed ID: 35871139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SHISA3 Reprograms Tumor-Associated Macrophages Toward an Antitumoral Phenotype and Enhances Cancer Immunotherapy.
    Zhang S; Yu B; Sheng C; Yao C; Liu Y; Wang J; Zeng Q; Mao Y; Bei J; Zhu B; Chen S
    Adv Sci (Weinh); 2024 Sep; 11(36):e2403019. PubMed ID: 39054639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization.
    Xu G; Feng D; Yao Y; Li P; Sun H; Yang H; Li C; Jiang R; Sun B; Chen Y
    Oncogene; 2020 Feb; 39(7):1429-1444. PubMed ID: 31659256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated macrophages (TAMs)-derived osteopontin (OPN) upregulates PD-L1 expression and predicts poor prognosis in non-small cell lung cancer (NSCLC).
    Li Y; Liu H; Zhao Y; Yue D; Chen C; Li C; Zhang Z; Wang C
    Thorac Cancer; 2021 Oct; 12(20):2698-2709. PubMed ID: 34423566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-κB inhibitor for antitumor immunotherapy.
    Xiao Z; Su Z; Han S; Huang J; Lin L; Shuai X
    Sci Adv; 2020 Feb; 6(6):eaay7785. PubMed ID: 32076650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cordyceps militaris polysaccharide converts immunosuppressive macrophages into M1-like phenotype and activates T lymphocytes by inhibiting the PD-L1/PD-1 axis between TAMs and T lymphocytes.
    Bi S; Huang W; Chen S; Huang C; Li C; Guo Z; Yang J; Zhu J; Song L; Yu R
    Int J Biol Macromol; 2020 May; 150():261-280. PubMed ID: 32044366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycocalyx-Mimicking Nanoparticles Improve Anti-PD-L1 Cancer Immunotherapy through Reversion of Tumor-Associated Macrophages.
    Zhang Y; Wu L; Li Z; Zhang W; Luo F; Chu Y; Chen G
    Biomacromolecules; 2018 Jun; 19(6):2098-2108. PubMed ID: 29634251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.
    Wu Q; Zhou W; Yin S; Zhou Y; Chen T; Qian J; Su R; Hong L; Lu H; Zhang F; Xie H; Zhou L; Zheng S
    Hepatology; 2019 Jul; 70(1):198-214. PubMed ID: 30810243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphoinositide 3-kinase/Akt and its related signaling pathways in the regulation of tumor-associated macrophages polarization.
    Yang D; Yang L; Cai J; Li H; Xing Z; Hou Y
    Mol Cell Biochem; 2022 Oct; 477(10):2469-2480. PubMed ID: 35590082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effect of nuclear factor-κB decoy transfer by mannose-modified bubble lipoplex into macrophages in mouse malignant ascites.
    Kono Y; Kawakami S; Higuchi Y; Maruyama K; Yamashita F; Hashida M
    Cancer Sci; 2014 Aug; 105(8):1049-55. PubMed ID: 24850474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 20. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.